Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

Palm Beach, FL – March 10, 2025 – A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 billion in 2024 to ...

Aclarion, Inc. (NASDAQ:ACON) experienced a dramatic decrease of 74.13% in its stock price. Elevai Labs, Inc. (ELAB) saw a substantial price drop of 42.63%. Sleep Number Corporation (SNBR) reported a ...

Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...

Lenox Hill Radiology (LHR) in New York and New Jersey Imaging Network (NJIN) to add Nociscan across multiple sites.

Inc trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Healthcare technology firm Aclarion Inc.'s (ACON) stock surged nearly 127% on Monday, marking its best single-day gain since ...

Aclarion shares are trading higher by 124% during Monday's session. The company announced it signed a commercial deal with ...

US equity futures rose ahead of Monday's opening bell as traders eyed a fresh batch of quarterly earnings updates from Corporate America due for release this week, including from major retailers. Dow ...

March 03, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented ...

Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro ...

Aclarion, Inc. (NASDAQ:ACON – Get Free Report) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 247,100 shares, an ...